BUTTERFLY NETWORK INC (BFLY) Stock Fundamental Analysis
USA - NYSE:BFLY - US1241551027 - Common Stock
2.262 USD
-0.1 (-4.15%)
Overall BFLY gets a fundamental rating of 4 out of 10. We evaluated BFLY against 191 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for BFLY as it has an excellent financial health rating, but there are worries on the profitability. BFLY is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
BFLY had negative earnings in the past year.
BFLY had a negative operating cash flow in the past year.
In the past 5 years BFLY always reported negative net income.
In the past 5 years BFLY always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -20.05%, BFLY perfoms like the industry average, outperforming 50.79% of the companies in the same industry.
BFLY has a Return On Equity (-26.99%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.05% | ||
| ROE | -26.99% | ||
| ROIC | N/A |
ROA(3y)-37.57%
ROA(5y)-30.05%
ROE(3y)-51.84%
ROE(5y)-42.67%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BFLY has a Gross Margin of 61.97%. This is in the better half of the industry: BFLY outperforms 63.87% of its industry peers.
In the last couple of years the Gross Margin of BFLY has grown nicely.
BFLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y29.74%
GM growth 5YN/A
2. Health
2.1 Basic Checks
BFLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
BFLY has more shares outstanding than it did 1 year ago.
BFLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
BFLY has an Altman-Z score of 1.07. This is a bad value and indicates that BFLY is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BFLY (1.07) is comparable to the rest of the industry.
There is no outstanding debt for BFLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.07 |
ROIC/WACCN/A
WACC8.67%
2.3 Liquidity
BFLY has a Current Ratio of 5.68. This indicates that BFLY is financially healthy and has no problem in meeting its short term obligations.
BFLY has a better Current ratio (5.68) than 82.20% of its industry peers.
A Quick Ratio of 4.14 indicates that BFLY has no problem at all paying its short term obligations.
BFLY has a better Quick ratio (4.14) than 77.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.68 | ||
| Quick Ratio | 4.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 45.10% over the past year.
The Revenue has grown by 23.13% in the past year. This is a very strong growth!
The Revenue has been growing by 9.46% on average over the past years. This is quite good.
EPS 1Y (TTM)45.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)23.13%
Revenue growth 3Y9.46%
Revenue growth 5YN/A
Sales Q2Q%8.82%
3.2 Future
BFLY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.27% yearly.
Based on estimates for the next years, BFLY will show a quite strong growth in Revenue. The Revenue will grow by 15.76% on average per year.
EPS Next Y23.76%
EPS Next 2Y12.17%
EPS Next 3Y9.27%
EPS Next 5YN/A
Revenue Next Year11.82%
Revenue Next 2Y15.58%
Revenue Next 3Y15.76%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BFLY. In the last year negative earnings were reported.
Also next year BFLY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.17%
EPS Next 3Y9.27%
5. Dividend
5.1 Amount
No dividends for BFLY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:BFLY (10/16/2025, 12:23:51 PM)
2.262
-0.1 (-4.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.07%
Inst Owner Change-0.02%
Ins Owners6.43%
Ins Owner Change2.6%
Market Cap569.44M
Analysts84
Price Target3.23 (42.79%)
Short Float %9.76%
Short Ratio4.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.69%
Min EPS beat(2)15.97%
Max EPS beat(2)29.41%
EPS beat(4)4
Avg EPS beat(4)18.44%
Min EPS beat(4)9.51%
Max EPS beat(4)29.41%
EPS beat(8)7
Avg EPS beat(8)10.56%
EPS beat(12)10
Avg EPS beat(12)11.02%
EPS beat(16)14
Avg EPS beat(16)20.22%
Revenue beat(2)0
Avg Revenue beat(2)-2.51%
Min Revenue beat(2)-3.37%
Max Revenue beat(2)-1.65%
Revenue beat(4)1
Avg Revenue beat(4)0.19%
Min Revenue beat(4)-3.37%
Max Revenue beat(4)6.06%
Revenue beat(8)4
Avg Revenue beat(8)2.1%
Revenue beat(12)5
Avg Revenue beat(12)-0.27%
Revenue beat(16)6
Avg Revenue beat(16)-2.41%
PT rev (1m)0%
PT rev (3m)-24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.76%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)7.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.51 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.45 | ||
| P/tB | 2.54 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.35
BVpS0.92
TBVpS0.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.05% | ||
| ROE | -26.99% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.97% | ||
| FCFM | N/A |
ROA(3y)-37.57%
ROA(5y)-30.05%
ROE(3y)-51.84%
ROE(5y)-42.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y29.74%
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 21.65% | ||
| Cap/Sales | 2.37% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.68 | ||
| Quick Ratio | 4.14 | ||
| Altman-Z | 1.07 |
F-Score6
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)129.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)12.33%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y23.76%
EPS Next 2Y12.17%
EPS Next 3Y9.27%
EPS Next 5YN/A
Revenue 1Y (TTM)23.13%
Revenue growth 3Y9.46%
Revenue growth 5YN/A
Sales Q2Q%8.82%
Revenue Next Year11.82%
Revenue Next 2Y15.58%
Revenue Next 3Y15.76%
Revenue Next 5YN/A
EBIT growth 1Y41.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.25%
EBIT Next 3Y23.01%
EBIT Next 5YN/A
FCF growth 1Y78.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.75%
OCF growth 3YN/A
OCF growth 5YN/A